Research reveals never-before-seen antibody binding and informing liver cancer and antibody design
In structural biology, some molecules are so unusual they can only be captured with a…
Browsing: neuroblastoma
New immunotherapy shows promise against rare childhood cancer
A novel CAR T-cell therapy developed by researchers at UCL, UK, and designed to target…
CAR NKT cells offer a promising novel immunotherapy for solid tumours
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer…
New drug targeting high-risk children’s cancer is ready for trials
A new drug that has passed safety tests in adults is likely to be effective…
Aggressive childhood cancer could be treated by combining DNA-damage targeting drugs
An aggressive form of the childhood cancer neuroblastoma could be treatable with two cancer drugs currently…
New treatment shows success in high-risk solid tumours
Despite intensive treatment, high-risk solid tumours like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to…
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblastoma
A type of drug known as a PARP inhibitor, already used to treat breast and…
MRI scan used for heart disease could also pick out aggressive cancers
A type of smart MRI scan used in people with heart disease could help assess…
Study could lead to new scale for stratifying neuroblastoma risk
Results from a study conducted by a research team led by C. Patrick Reynolds, M.D.,…
New method for monitoring residual disease after treatment in children with neuroblastoma
A research group led by Professor Nishimura Noriyuki (Graduate School of Health Sciences, Kobe University,…